TESARO competitorsClear all

TESARO's top competitors include BeyondSpring, Mirati Therapeutics, Northwest Biotherapeutics and Ablynx.
TESARO
TESARO
TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
BeyondSpring
BeyondSpring
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company.
Mirati Therapeutics
Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of oncology products including candidates intended to treat specific genetic and epigenetic drivers of cancer in selected subsets of cancer patients with unmet needs.
Northwest Biotherapeutics
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Founding Date
Founding Date
2010
Founding Date
2010
Founding Date
2013
Founding Date
1998
Founding Date
2001
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Waltham, US HQ
Wien, AT
Boulogne Billancourt, FR
München, DE
Roma, IT
Madrid, ES
Zug, CH
see more
Locations
New York, US HQ
Locations
San Diego, US HQ
Locations
Bethesda, US HQ
Locations
Gent, BE HQ
Gent, BE
Employees
Employees
446
Employees
6117% increase
Employees
11176% increase
Employees
1721% increase
Employees
4061% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
442.5 m
Valuation ($)
7.2 b
Valuation ($)
665.9 m
Valuation ($)
N/A
Twitter followers
Twitter followers
2.3 k
Twitter followers
75
Twitter followers
265
Twitter followers
2.1 k
Twitter followers
254
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
279743
Alexa Website Rank
416085
Alexa Website Rank
336563
Alexa Website Rank
318239
Employee Rating
Employee Rating
3.8
Employee Rating
2.3
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.1

Financial

Revenue (est.)
Revenue (est.)
$223.3m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$3.3m (FY, 2019)
Revenue (est.)
$2.4m (FY, 2019)
Revenue (est.)
€85.2m (FY, 2016)
Net income
Net income
($496.1m) (FY, 2017)
Net income
($40.3m) (FY, 2019)
Net income
($213.3m) (FY, 2019)
Net income
($20.3m) (FY, 2019)
Net income
(€1.1m) (FY, 2016)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
20 (Mar, 2020)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
50 (Q2, 2017)

Funding

Total funding raised
Total funding raised
$ 161m
Total funding raised
$ 36.1m
Total funding raised
N/A
Total funding raised
$ 135.9m
Total funding raised
$ 498.8m
For sources of this data, please see the company profile

View company profiles

BeyondSpring
HQ
New York, US
Employees
61↑ 17% increase

BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company.

View company
Mirati Therapeutics
HQ
San Diego, US
Employees
111

Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of oncology products including candidates intended to treat specific genetic and epigenetic drivers of cancer in selected subsets of cancer patients with unmet needs.

View company
Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

View company
Ablynx
HQ
Gent, BE

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

View company